Rosen Law Firm Encourages Vistagen Investors to Secure Counsel Before Deadline

Investors with losses over $100K in Vistagen Therapeutics stock urged to act before March 16, 2026 lead plaintiff deadline.

Feb. 15, 2026 at 7:31am

Got story updates? Submit your updates here. ›

The Rosen Law Firm, a global investor rights law firm, is reminding purchasers of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025 of the important March 16, 2026 lead plaintiff deadline in a securities class action lawsuit against the company.

Why it matters

The lawsuit alleges that Vistagen provided investors with materially false and misleading information about the development and commercialization of its drug fasedienol, an investigational pherine candidate for social anxiety disorder. Investors who purchased Vistagen stock during the class period may be entitled to compensation.

The details

According to the lawsuit, Vistagen made positive assertions about fasedienol's future trial success and the likelihood of Phase 3 success, while at the same time disseminating false and misleading statements and/or concealing material adverse facts concerning the PALISADE-3 clinical trial. When the true details entered the market, investors allegedly suffered damages.

  • The class period is from April 1, 2024 to December 16, 2025.
  • The lead plaintiff deadline is March 16, 2026.

The players

Vistagen Therapeutics, Inc.

A biopharmaceutical company developing novel medicines for central nervous system (CNS) disorders.

Rosen Law Firm

A global investor rights law firm that represents investors throughout the world, concentrating its practice in securities class actions and shareholder derivative litigation.

Got photos? Submit your photos here. ›

What they’re saying

“We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition.”

— Laurence Rosen, Founding Partner, Rosen Law Firm

What’s next

To join the Vistagen class action, investors can go to https://rosenlegal.com/submit-form/?case_id=50827 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action. The deadline to move the Court to serve as lead plaintiff is March 16, 2026.

The takeaway

This case highlights the importance for investors to carefully select qualified legal counsel with a proven track record when pursuing securities class actions, as the choice of counsel can significantly impact the potential outcome of the litigation.